Medicare Compliance & Reimbursement - 2004 Issue 13
Physician Notes: CMS Mulls Taking Drugs Out Of Update Formula
Subscribe or sign in to view the full article.
Article Overview
This physician-focused news piece discusses Medicare payment policy developments tied to the Sustainable Growth Rate framework, including CMS discussion of drug cost treatment in spending calculations and the broader implications for physician reimbursement. It also notes a Medicare coverage reaffirmation involving sensory nerve conduction threshold testing and reports on a fraud conviction involving diagnostic testing claims. The article is relevant to physicians, billing and coding professionals, compliance staff, and anyone tracking Medicare policy and enforcement updates.
Why This Topic Matters
It helps readers follow policy and enforcement changes that can affect physician reimbursement, Medicare coverage determinations, and claims compliance oversight.
Article Sections
-
Medicare physician payment and the Sustainable Growth Rate
Discusses Medicare physician payment pressures, the Sustainable Growth Rate framework, and CMS-related consideration of what is included in spending calculations.
-
Coverage reaffirmation and enforcement update
Summarizes a Medicare coverage reaffirmation and a fraud case involving diagnostic testing claims and related allegations.
What You Will Learn
- How Medicare physician payment policy developments can affect reimbursement trends
- What type of CMS activity is being discussed in relation to physician spending calculations
- Which coverage and compliance issues are highlighted in the news update
- Why diagnostic testing claims are part of the broader billing and enforcement discussion
Who Should Read This
- Physicians
- Medical coders
- Billing specialists
- Practice managers
- Compliance officers
- Revenue cycle staff
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com